{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:31:35Z","timestamp":1742646695638,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15283","19H03375"],"award-info":[{"award-number":["22K15283","19H03375"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education, Sports, Science, Culture, and Technology of Japan","award":["23116515"],"award-info":[{"award-number":["23116515"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00011-024-01902-8","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:44:12Z","timestamp":1717494252000},"page":"1349-1358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostacyclin synthase deficiency exacerbates systemic inflammatory responses in lipopolysaccharide-induced septic shock in mice"],"prefix":"10.1007","volume":"73","author":[{"given":"Tsubasa","family":"Ochiai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Honsawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuntaro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"1902_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320. https:\/\/doi.org\/10.1038\/nri.2017.36.","journal-title":"Nat Rev Immunol"},{"key":"1902_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/s0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"1902_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharmthera.2017.02.040","volume":"177","author":"Y Hattori","year":"2017","unstructured":"Hattori Y, Hattori K, Suzuki T, Matsuda N. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: novel therapeutic implications and challenges. Pharmacol Ther. 2017;177:56\u201366. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.040.","journal-title":"Pharmacol Ther"},{"key":"1902_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1378\/chest.103.2.565","volume":"103","author":"MR Pinsky","year":"1993","unstructured":"Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103:565\u201375. https:\/\/doi.org\/10.1378\/chest.103.2.565.","journal-title":"Chest"},{"key":"1902_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/ccm.0000000000002014","volume":"45","author":"J Dalli","year":"2017","unstructured":"Dalli J, Colas RA, Quintana C, et al. Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes. Crit Care Med. 2017;45:58\u201368. https:\/\/doi.org\/10.1097\/ccm.0000000000002014.","journal-title":"Crit Care Med"},{"key":"1902_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2183\/pjab.93.044","volume":"93","author":"S Hara","year":"2017","unstructured":"Hara S. Prostaglandin terminal synthases as novel therapeutic targets. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:703\u201323. https:\/\/doi.org\/10.2183\/pjab.93.044.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1902_CR7","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/cc11211","volume":"16","author":"BH Lee","year":"2012","unstructured":"Lee BH, Inui D, Suh GY, et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012;16:R33. https:\/\/doi.org\/10.1186\/cc11211.","journal-title":"Crit Care"},{"key":"1902_CR8","doi-asserted-by":"publisher","first-page":"15197","DOI":"10.1096\/fj.202001481R","volume":"34","author":"T Maehara","year":"2020","unstructured":"Maehara T, Higashitarumi F, Kondo R, Fujimori K. Prostaglandin F2\u03b1 receptor antagonist attenuates LPS-induced systemic inflammatory response in mice. FASEB J. 2020;34:15197\u2013207. https:\/\/doi.org\/10.1096\/fj.202001481R.","journal-title":"FASEB J"},{"key":"1902_CR9","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.4049\/jimmunol.1102330","volume":"188","author":"M Ishii","year":"2012","unstructured":"Ishii M, Asano K, Namkoong H, et al. CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis. J Immunol. 2012;188:5655\u201364. https:\/\/doi.org\/10.4049\/jimmunol.1102330.","journal-title":"J Immunol"},{"key":"1902_CR10","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1128\/iai.63.8.3101-3105.1995","volume":"63","author":"MA Choudhry","year":"1995","unstructured":"Choudhry MA, Ahmad S, Sayeed MM. Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis. Infect Immun. 1995;63:3101\u20135. https:\/\/doi.org\/10.1128\/iai.63.8.3101-3105.1995.","journal-title":"Infect Immun"},{"key":"1902_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1248\/bpb.b22-00370","volume":"45","author":"T Ochiai","year":"2022","unstructured":"Ochiai T, Honsawa T, Sasaki Y, Hara S. Prostacyclin Synthase as an ambivalent regulator of inflammatory reactions. Biol Pharm Bull. 2022;45:979\u201384. https:\/\/doi.org\/10.1248\/bpb.b22-00370.","journal-title":"Biol Pharm Bull"},{"key":"1902_CR12","doi-asserted-by":"publisher","first-page":"e21952","DOI":"10.1096\/fj.202101025R","volume":"35","author":"T Ochiai","year":"2021","unstructured":"Ochiai T, Sasaki Y, Yokoyama C, Kuwata H, Hara S. Absence of prostacyclin greatly relieves cyclophosphamide-induced cystitis and bladder pain in mice. FASEB J. 2021;35:e21952. https:\/\/doi.org\/10.1096\/fj.202101025R.","journal-title":"FASEB J"},{"key":"1902_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2021.02.004","volume":"546","author":"T Ochiai","year":"2021","unstructured":"Ochiai T, Sasaki Y, Kuwata H, Nakatani Y, Yokoyama C, Hara S. Coordinated action of microsomal prostaglandin E synthase-1 and prostacyclin synthase on contact hypersensitivity. Biochem Biophys Res Commun. 2021;546:124\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.004.","journal-title":"Biochem Biophys Res Commun"},{"key":"1902_CR14","doi-asserted-by":"publisher","first-page":"103454","DOI":"10.15252\/embj.2019103454","volume":"39","author":"N Ipseiz","year":"2020","unstructured":"Ipseiz N, Pickering RJ, Rosas M, et al. Tissue-resident macrophages actively suppress IL-1beta release via a reactive prostanoid\/IL-10 pathway. EMBO J. 2020;39:103454.","journal-title":"EMBO J"},{"key":"1902_CR15","doi-asserted-by":"publisher","first-page":"e23330","DOI":"10.1096\/fj.202301314R","volume":"37","author":"H Kuwata","year":"2023","unstructured":"Kuwata H, Nakatani E, Tomitsuka Y, et al. Deficiency of long-chain acyl-CoA synthetase 4 leads to lipopolysaccharide-induced mortality in a mouse model of septic shock. FASEB J. 2023;37:e23330. https:\/\/doi.org\/10.1096\/fj.202301314R.","journal-title":"FASEB J"},{"key":"1902_CR16","doi-asserted-by":"publisher","first-page":"e22739","DOI":"10.1096\/fj.202200483RRR","volume":"37","author":"L Liu","year":"2023","unstructured":"Liu L, Xu M, Zhang Z, et al. TRPA1 protects mice from pathogenic Citrobacter rodentium infection via maintaining the colonic epithelial barrier function. FASEB J. 2023;37:e22739. https:\/\/doi.org\/10.1096\/fj.202200483RRR.","journal-title":"FASEB J"},{"key":"1902_CR17","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1292\/jvms.57.1041","volume":"57","author":"Y Takeuchi","year":"1995","unstructured":"Takeuchi Y, Kikusui T, Mori Y. Changes in the behavioral parameters following the lipopolysaccharide administration in goats. J Vet Med Sci. 1995;57:1041\u20134. https:\/\/doi.org\/10.1292\/jvms.57.1041.","journal-title":"J Vet Med Sci"},{"key":"1902_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1248\/bpb.b21-01057","volume":"45","author":"H Chen","year":"2022","unstructured":"Chen H, Shen Y, Liang Y, Qiu Y, Xu M, Li C. Selexipag improves lipopolysaccharide-induced ARDS on C57BL\/6 mice by modulating the cAMP\/PKA and cAMP\/Epac1 signaling pathways. Biol Pharm Bull. 2022;45:1043\u201352. https:\/\/doi.org\/10.1248\/bpb.b21-01057.","journal-title":"Biol Pharm Bull"},{"key":"1902_CR19","doi-asserted-by":"publisher","first-page":"e2113872119","DOI":"10.1073\/pnas.2113872119","volume":"119","author":"HI Muendlein","year":"2022","unstructured":"Muendlein HI, Connolly WM, Magri Z, et al. ZBP1 promotes inflammatory responses downstream of TLR3\/TLR4 via timely delivery of RIPK1 to TRIF. Proc Natl Acad Sci U S A. 2022;119:e2113872119. https:\/\/doi.org\/10.1073\/pnas.2113872119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1902_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2016.05.019","volume":"626","author":"A Nassar","year":"2016","unstructured":"Nassar A, Sharon-Granit Y, Azab AN. Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats. Neurosci Lett. 2016;626:59\u201367. https:\/\/doi.org\/10.1016\/j.neulet.2016.05.019.","journal-title":"Neurosci Lett"},{"key":"1902_CR21","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1523\/jneurosci.2887-19.2020","volume":"40","author":"NLS Machado","year":"2020","unstructured":"Machado NLS, Bandaru SS, Abbott SBG, Saper CB. EP3R-expressing glutamatergic preoptic neurons mediate inflammatory fever. J Neurosci. 2020;40:2573\u201388. https:\/\/doi.org\/10.1523\/jneurosci.2887-19.2020.","journal-title":"J Neurosci"},{"key":"1902_CR22","doi-asserted-by":"publisher","first-page":"17376","DOI":"10.1038\/srep17376","volume":"5","author":"Y Sasaki","year":"2015","unstructured":"Sasaki Y, Kamiyama S, Kamiyama A, et al. Genetic-deletion of cyclooxygenase-2 downstream prostacyclin synthase suppresses inflammatory reactions but facilitates carcinogenesis, unlike deletion of microsomal prostaglandin E synthase-1. Sci Rep. 2015;5:17376. https:\/\/doi.org\/10.1038\/srep17376.","journal-title":"Sci Rep"},{"key":"1902_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.prostaglandins.2018.04.001","volume":"136","author":"S Toki","year":"2018","unstructured":"Toki S, Zhou W, Goleniewska K, et al. Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model. Prostaglandins Other Lipid Mediat. 2018;136:33\u201343. https:\/\/doi.org\/10.1016\/j.prostaglandins.2018.04.001.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1902_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4049\/jimmunol.1501063","volume":"197","author":"W Zhou","year":"2016","unstructured":"Zhou W, Zhang J, Goleniewska K, et al. Prostaglandin I2 suppresses proinflammatory chemokine expression, CD4 T cell activation, and STAT6-independent allergic lung inflammation. J Immunol. 2016;197:1577\u201386. https:\/\/doi.org\/10.4049\/jimmunol.1501063.","journal-title":"J Immunol"},{"key":"1902_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bjp.0704872","volume":"137","author":"Y Takahashi","year":"2002","unstructured":"Takahashi Y, Tokuoka S, Masuda T, et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol. 2002;137:315\u201322. https:\/\/doi.org\/10.1038\/sj.bjp.0704872.","journal-title":"Br J Pharmacol"},{"key":"1902_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.taap.2017.09.003","volume":"334","author":"H Misawa","year":"2017","unstructured":"Misawa H, Ohashi W, Tomita K, et al. Prostacyclin mimetics afford protection against lipopolysaccharide\/d-galactosamine-induced acute liver injury in mice. Toxicol Appl Pharmacol. 2017;334:55\u201365. https:\/\/doi.org\/10.1016\/j.taap.2017.09.003.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1902_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/jpet.107.124248","volume":"322","author":"K Kuwano","year":"2007","unstructured":"Kuwano K, Hashino A, Asaki T, et al. 2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug. J Pharmacol Exp Ther. 2007;322:1181\u20138. https:\/\/doi.org\/10.1124\/jpet.107.124248.","journal-title":"J Pharmacol Exp Ther"},{"key":"1902_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1388-1981(99)00164-x","volume":"1483","author":"M Abramovitz","year":"2000","unstructured":"Abramovitz M, Adam M, Boie Y, et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta. 2000;1483:285\u201393. https:\/\/doi.org\/10.1016\/s1388-1981(99)00164-x.","journal-title":"Biochim Biophys Acta"},{"key":"1902_CR29","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","volume":"373","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Channick R, Chin KM, et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373:2522\u201333. https:\/\/doi.org\/10.1056\/NEJMoa1503184.","journal-title":"N Engl J Med"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01902-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01902-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:40:28Z","timestamp":1722030028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01902-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1902"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01902-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"type":"print","value":"1023-3830"},{"type":"electronic","value":"1420-908X"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state explicitly that there are no conflicts of interest in connection with this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}